Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Methodology

ABSTRACT: The sample condition is important factor in urine proteomics for biomarker discovery with stability and high accuracy. However, it hasn’t been defined that the general method of urine protein preparation for mass spectrometry analysis. In this study, we proposed the workflow for optimal sample preparation based on methanol/chlroform precipitation and trypsin digestion in urine proteomics.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Tadashi Yamamoto

PROVIDER: PXD010517 | JPOST Repository | Sat Jul 20 00:00:00 BST 2019

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ACN1_1.raw	Raw
	ACN1_2.raw	Raw
	ACN2_1.raw	Raw
	ACN2_2.raw	Raw
	act1-1.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Impact of Sample Preparation Strategies on The Quantitative Accuracy of Low-Abundance Serum Proteins in Shotgun Proteomics

Project description:Serum proteomics plays a crucial role in biomarker discovery and disease research, yet the selection of an optimal sample preparation method remains challenging. Evaluating the accuracy of protein quantitation is of major importance and a vital part of a benchmarking study in proteomics, since clinical studies are based on the differential expression of certain proteins that can be used as biomarkers or be indicative for a pathological state. In this study, we performed a direct comparison of 6 widely used serum proteomic sample preparation workflows: In-gel digestion (IGD), Single-Pot Solid-Phase-enhanced Sample Preparation (SP3), Top 14 Abundant Protein Depletion (Top 14), Isopropanol/Trichloroacetic Acid (IPA/TCA) precipitation, PreOmics ENRICH-iST (PreOmics), and Seer Proteograph XT (Seer). Seer and PreOmics demonstrated superior quantitative accuracy especially for proteins with low abundance in serum while Seer enrichment approach provided the highest number of protein identifications (> 2000) as measured by an Orbitrap Exploris 480. All methods had median CVs close to or below 20%. This comparative analysis provides a comprehensive resource for selecting the most appropriate serum sample preparation strategy based on specific experimental needs, facilitating human serum proteomic profiling for biomedical research.

2025-09-15 | PXD062785 | Pride

Comprehensive Comparison of Sample Preparation workflow for Large Scaled Proteome Identification

Project description:An optimal sample preparation workflow for highly efficient and unbiased to global proteomic analysis in the human tissues.

2021-12-16 | PXD030434 |

Urine proteome in patients with metabolic associated fatty liver disease

Project description:Background Metabolic associated fatty liver disease (MAFLD) was recently proposed to replace non-alcoholic fatty liver disease (NAFLD), which is defined as ectopic fat deposition in the liver. Hepatic steatosis is an independent predictor for insulin resistance and cardiovascular risk and hence mortality. The aim of present study was to investigate the urine molecular pattern and potential urine biomarker to distinguish healthy control, mild and severe hepatic steatosis in MAFLD patients using proteomic data. Method Hepatic steatosis was measured by Magnetic resonance imaging (MRI) that measure the proton density fat fraction (MRI-PDFF). Proteomic measurements of urine samples were done by mass spectrometry. Linear regression analyses were used to detect significant associations between the biomarkers and clinical parameters. Western blot and Elisa were performed for validation. Results Multiple pathways have been compromised in MAFLD, including the carbohydrate derivative catabolic process, glycosaminoglycan process, aminoglycan metabolic process, inflammatory response, insulin-like growth factor receptor and GTPase complex. Alpha-1-acid glycoprotein 1 (ORM1) and ceruloplasmin were finally identified to be potential urine biomarkers to detect mild/severe hepatic steatosis.

2022-08-12 | PXD026333 | Pride

The effect of sample splitting and technical replication on mRNA-seq and sRNA-seq quantification

Project description:RNA sequencing (RNA-seq) is a widely used method for quantifying RNA levels across the environmental, biological and medical sciences. The accuracy of the output from an RNA-seq experiment is known to vary due to sequencing biases or errors in quantification. These have the potential to lead to false calls of differential expression (DE), and hence, to affect the accuracy of the biological inference. A proposed solution to reduce the number of false positives and increase confidence in the quality of results from such experiments is to increase the number of biological replicates. In addition, more recent suggestions are to create additional technical replicates within biological replicates (i.e. to split samples across sequencing lanes). The optimal strategy for analysing and normalizing such data, and for maximising accuracy as a function of cost, biological and technical replication is important to understand, yet currently unclear. The aim of this study was to test the effect of technical replication and sample splitting on the overall outcome of gene expression profiling for RNA-seq data.

2018-12-15 | GSE85806 | GEO

Frontiers in Plasma Proteome Profiling Platforms: Innovations and Applications.

Project description:Biomarkers play a crucial role in advancing precision medicine by enabling more targeted and individualized approaches to diagnosis and treatment. Various biofluids, including serum, plasma, cerebrospinal fluid (CSF), saliva, tears, pancreatic cyst fluids, and urine, have been identified as rich sources of potential biomarkers. In this study, our focus is on comparing workflows for plasma proteomic profiling to establish a methodology that is not only sensitive and reproducible but also applicable for large cohort studies in biomarker discovery. Our investigation revealed that the SeerProteographXT workflow outperforms other workflows in terms of plasma proteome depth, quantitative accuracy, and reproducibility while offering complete automation of sample preparation. Notably, SeerProteographXT demonstrates versatility by applying it to various types of biofluids. Additionally, the proteins quantified widely cover secretory proteins in peripheral blood, and the pathway analysis enriched with relevant components such as interleukins, tissue necrosis factors, chemokines, and B and T cell receptors provides valuable insights. These proteins, often challenging to quantify in complex biological samples, hold potential as early detection markers for various diseases, thereby contributing to the improvement of patient care quality.

2024-07-03 | PXD050425 | Pride

Comparison of performances of automatic versus manual liquid handling in density-based separation of extracellular vesicles from plasma and urine

Project description:Extracellular vesicles (EV) in body fluids are extensively studied as potential biomarkers for numerous diseases. Major impediments of EV-based biomarker discovery include the manual labor, and the specificity and reproducibility of EV sample preparation. To tackle this, we present an automated liquid handling workstation for the density-based separation of EV from human body fluids and compare its performance to manual handling by (in)experienced researchers. To validate automated density-based separation of EVs from human body fluids, including blood plasma and urine, we assess variation, yield and purity by mass spectrometry-based proteomics.

2023-05-10 | PXD032394 | Pride

Fully automated workflow for integrated sample digestion and Evotip loading enabling high-throughput clinical proteomics

Project description:Protein identification and quantification is an important tool for biomarker discovery. With the increased sensitivity and speed of modern mass spectrometers, sample-preparation remains a bottleneck for studying large cohorts. To address this issue, we prepared and evaluated a simple and efficient workflow on the Opentrons OT-2 (OT-2) robot that combines sample digestion, cleanup and Evotip loading in a fully automated manner, allowing the processing of up to 192 samples in 6 hours. Our results demonstrate a highly sensitive workflow yielding both reproducibility and stability even at low sample inputs. The workflow is optimized for minimal sample starting amount to reduce the costs for reagents needed for sample preparation, which is critical when analyzing large biological cohorts. Building on the digesting workflow, we incorporated an automated phosphopeptide enrichment step using magnetic Ti-IMAC beads. This allows for a fully automated proteome and phosphoproteome sample preparation in a single step with high sensitivity. Using the integrated workflow, we evaluated the effects of cancer immune therapy on the plasma proteome in metastatic melanoma patients.

2024-06-12 | PXD048325 | Pride

Comparative evaluation of different sample preparation workflows for reproducible, quantitative, and in-depth analysis of urine proteomics

Project description:The growing field of urinary proteomics has provided a promising opportunity to identify biomarkers useful for diagnosis and prognostication of a number of diseases. Urine is abundant and readily collected in a non-invasive manner which makes it eminently available for testing, however sample preparation for proteomics analysis remains one of the biggest challenges in this field. As newer technologies to analyze tandem mass spectrometry (MS) data develop, utility of urinary proteomics would be enhanced by better sample processing and separation workflows to generate fast, reproducible, and more in-depth proteomics data. In this study, we have evaluated the performance of four sample preparation methods: MStern, PreOmics In-StageTip (iST), Suspension-trapping (S-Trap), and conventional urea In-Solution trypsin hydrolysis for non-depleted urine samples. Data Dependent Acquisition (DDA) mode on QE-HF was used for single-shot label-free data acquisition. Our results demonstrate a high degree of reproducibility within each workflow. PreOmics iST yields the best digestion efficiency with lowest percentage of missed-cleavage peptides. S-trap workflow gave the greatest number of peptide and protein identifications. Using S-trap method, with 0.5mL urine sample as starting material, we identify ~1500 protein groups and ~17700 peptides from DDA analysis with a single injection. The continued refinement of sample preparation (presented here), LC separation methods and mass spectrometry data acquisition can allow the integration of information rich urine proteomic records across large cohorts with other ‘big data’ initiatives becoming more popular in medical research.

2020-03-06 | PXD016273 | Pride

Comparison of six methods for isolation of urinary microvesicles for miRNA profiling in proteinuria.

Project description:Urinary extracellular vesicles (uEVs) are a promising source for biomarker discovery, including miRNAs. The optimal isolation method of uEVs for miRNA profiling in patients with proteinuria is unknown. Six different methods were compared for the isolation of microvesicles and these were compared to raw urine (method A). 2 methods failed and further analysis was performed with the following methods: ExoRNeasy (method C), modified protocol for ExoRNeasy (method E) and ultracentrifugation (method F). Different miRNAs are enriched by method C and F. No differences were observed between method C and E.

2020-08-01 | GSE102627 | GEO

Analysis of miRNA expression in urine of Hirschsprung's disease (HSCR) patients

Project description:Urine miRNA signature as potential non-invasive diagnostic biomarker for Hirschsprung’s Disease (HSCR): Unfortunately, HSCR diagnosis remains a challenge: current diagnostic methods are too invasive and difficult to conduct and to interpret. We designed this study in urine with the aim of identifying a non-invasive biomarker, which undoubtfully, would be a more convenient method for both babies and parents in the future.

2025-01-13 | GSE277874 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data